LY-3971297

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameLY-3971297
Drug Alias NameLY3971297LY-3971297
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAtrial natriuretic peptide receptor agonists
TargetsAtrial natriuretic peptide receptor
Therapy Area/IndicationsObesityHypertensionHeart Failure, Systolic +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsObesityHypertensionHeart Failure, Systolic +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A